在CAR-T疗法中使用人性化免疫系统小鼠的进展,影响和挑战-应用评估和改进
1NHC Key Laboratory of Human Disease Comparative Medicine, Institute of Laboratory Animal Sciences, CAMS and PUMC, Chao-yang District, Beijing, China.
Animal models and experimental medicine
|October 12, 2023
概括
人性化免疫系统 (HIS) 的小鼠为癌症和抗病毒疗法提供了卓越的临床前模型,比传统模型更好地模拟人类状况. 这些先进的HIS小鼠增强了仿真抗原受体 (CAR) -T细胞治疗的发展和临床转化.
科学领域:
- 免疫学 免疫学 免疫学
- 临床前研究 临床前研究
- 在瘤学瘤学.
背景情况:
- 人性化免疫系统 (HIS) 的小鼠越来越多地被用于临床前研究,在模仿人类免疫反应和瘤微环境方面表现优于传统的免疫缺陷模型.
- 瘤和其他领域的突破突出显示了HIS小鼠在评估新疗法的潜力.
研究的目的:
- 审查和评估HIS小鼠在临床前研究中用于仿真抗原受体 (CAR) -T细胞疗法的应用.
- 通过总结抗病毒和抗瘤治疗的流行和突破性研究来促进HIS小鼠的更广泛采用.
主要方法:
- 选择性总结目前对HIS小鼠和CAR-T细胞应用的研究.
- 探索HIS小鼠在反映临床患者状况和提供检测指标方面的实用性.
- 分析改善HIS小鼠模型的策略,包括减少抗宿主反应和纳入有机体替代.
主要成果:
- 与传统免疫缺陷小鼠相比,HIS小鼠更好地模拟临床患者条件和瘤免疫微环境.
- 在HIS小鼠中进行的CAR-T细胞治疗研究显示了高效检测指标,支持进步的研究和开发.
- 拟议的模型改进包括减少反宿主反应,组合模型和统一来源以提高实用性.
结论:
- 与传统模型相比,HIS小鼠为CAR-T细胞疗法开发提供了一个比传统模型更具临床相关性的平台.
- 进一步开发HIS模型可以解决局限性,并扩大其在临床前研究中的应用.
- 在CAR-T治疗中管理复发和毒性的策略对于未来的治疗进展至关重要.
相关概念视频
02:43Mouse Models of Cancer Study
5.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K
01:27Tumor Immunotherapy
539
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
539